RadNet
RDNT · NASDAQ
Bulios Fair Price
$46.14
40.7% downside
Current Price
$77.78
According to Bulios Fair Price, RDNT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
RadNet, Inc. (RDNT) is an American company specializing in providing diagnostic imaging services and outpatient healthcare. With an extensive network of radiology centers across the United States, RadNet is one of the leading providers of advanced diagnostic services for physicians and patients. The company focuses on providing a wide range of high-quality imaging examinations, including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT), as well as innovative technologies that aid in timely and accurate disease diagnosis. RadNet, Inc. (RDNT) could be suitable for investors seeking opportunities in the healthcare sector with an emphasis on diagnostic services and advanced imaging technologies.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Howard G. Berger
Employees
9,060
Headquarters
Los Angeles
Upcoming events
Earnings
Upcoming earnings report